JEOL receives Omega Award; SGE and Australian Proteome Analysis Facility sign agreement; Spark Holland achieves ISO certification; Waters and Northeastern University open laboratory; Eksigent signs Korean distribution agreement
JEOL receives Omega Award
For the seventh consecutive year, JEOL USA, Inc. (Peabody, Massachusetts), has received the Omega NorthFace Scoreboard Award in recognition of its commitment to providing exemplary service and exceeding customer expectations.
"We at JEOL are proud of our continuous and measurable improvement over the years," said Patrick McGinley, Director of Service. "Supplying excellent service requires a corporate-wide commitment to satisfying the customer's needs."
SGE and Australian Proteome Analysis Facility sign agreement
SGE Analytical Science (Austin, Texas) announced it has entered into a memorandum of understanding under an Australian government commercial-ready grant with Australian Proteome Analysis Facility, Ltd. (Sydney, Australia), a leading international proteomics service provider and technology developer for the development of applications of SGE's liquid chromatography and micro fabrication technologies.
APAF and SGE plan to collaborate on the development and commercialization of new chromatography products for the protein biomarker discovery markets. APAF will publicise SGE's products under its services and skill-training programs to its customers and develop new ProteCol kits for a variety of applications. Once feasibility is established, customers will then purchase the kits directly from SGE.
Spark Holland achieves ISO certification
Spark Holland BV (Emmen, the Netherlands) received the ISO 13485:2003 certificate from its notifying body, the KEMA. This ISO quality system is designed for companies delivering to the clinical market. Spark Holland has registered its Symbiosis Pharma system as an FDA Class 1 Medical device and certified it as a CE IVD device. The Symbiosis system accepts raw biological samples, like plasma or urine, cleans them up, performs LC separation and then injects it directly into the MS.
Waters and Northeastern University open laboratory
Waters Corporation (Milford, Massachuesetts) and Northeastern University today opened the doors of the Waters Mass Spectrometry Laboratory within the Barnett Institute of Chemical and Biological Analysis. The new laboratory is dedicated to studying protein shapes and characteristics to provide pharmaceutical and biotechnology innovators with the tools necessary to develop new treatment options for some of the world's deadiest diseases, like AIDS and cancer.
Eksigent signs Korean distribution agreement
Eksigent (Dublin, California) announced a distribution agreement with Interface Engineering (Seoul, South Korea), a division of Bio-Medical Science Co., Ltd. The agreement covers sales and service of the NanoLC and ExpressLC HPLC product lines in Korea.
Interface Engineering Co., Ltd. has been serving local clients and is a Korea's leading companies in the analytical field, especially in pharmaceutical and environmental research markets.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.